Wave Life Sciences Ltd’s recent filing unveils that its Director Verdine Gregory L. unloaded Company’s shares for reported $0.21 million on Jun 13 ’25. In the deal valued at $6.95 per share,30,000 shares were sold. As a result of this transaction, Verdine Gregory L. now holds 282,517 shares worth roughly $2.35 million.
Then, GREGORY VERDINE bought 30,000 shares, generating $216,000 in total proceeds.
Before that, HENRY CHRISTIAN O sold 10,500 shares. Wave Life Sciences Ltd shares valued at $102,574 were divested by the Director at a price of $9.77 per share. As a result of the transaction, HENRY CHRISTIAN O now holds 16,115 shares, worth roughly $0.13 million.
Oppenheimer initiated its Wave Life Sciences Ltd [WVE] rating to an Outperform in a research note published on July 28, 2025; the price target was $24. A number of analysts have revised their coverage, including Citigroup’s analysts, who began to cover the stock in mid July with a ‘”a Buy”‘ rating. Cantor Fitzgerald started covering the stock on April 29, 2025. It rated WVE as “an Overweight”.
Price Performance Review of WVE
On Tuesday, Wave Life Sciences Ltd [NASDAQ:WVE] saw its stock jump 1.71% to $8.32. Over the last five days, the stock has gained 4.92%. Wave Life Sciences Ltd shares have risen nearly 32.06% since the year began. Nevertheless, the stocks have fallen -32.74% over the past one year. While a 52-week high of $16.74 was reached on 01/03/25, a 52-week low of $5.04 was recorded on 04/09/25.
Levels Of Support And Resistance For WVE Stock
The 24-hour chart illustrates a support level at 8.03, which if violated will result in even more drops to 7.74. On the upside, there is a resistance level at 8.48. A further resistance level may holdings at 8.64.
How much short interest is there in Wave Life Sciences Ltd?
A steep rise in short interest was recorded in Wave Life Sciences Ltd stocks on 2025-07-15, growing by 1.52 million shares to a total of 16.41 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 14.88 million shares. There was a rise of 9.29%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on April 08, 2025 when Wedbush began covering the stock and recommended ‘”an Outperform”‘ rating along with a $18 price target.
